Ignite Creation Date:
2024-05-06 @ 9:34 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03016468
Status:
WITHDRAWN
Last Update Posted:
2017-04-11
First Post:
2017-01-06
Brief Title:
Safety of Transition From Selexipag to Remodulin Then Oral Treprostinil in Symptomatic Adult PAH
Sponsor:
United Therapeutics
Organization:
United Therapeutics
Organization Data
Organization:
United Therapeutics
Class:
INDUSTRY
Study ID:
TDE-PH-207
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
United Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None